FunPep Co (TSE:4881) 3-1 Month Momentum %: -17.74% (As of Sep. 21, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4881 FunPep Co Ltd TSE:4881
50 GF Score
Price 円50.00
GF Value 円156.75
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is FunPep Co 3-1 Month Momentum %?

FunPep Co TSE:4881 +2.04% 50 3-1 Month Momentum % is -17.74% as of Sep. 21, 2026. GuruFocus rates TSE:4881 with a GF Score™ of 50/100 and a GF Value™ of 円156.75 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 1,382 Biotechnology companies, FunPep Co ranks worse than 80.03% on this metric.

3-1 Month Momentum % is the total return of the stock from 3-month ago to 1-month ago. As of today (2026-09-21), FunPep Co's 3-1 Month Momentum % is -17.74%.

The industry rank for FunPep Co's 3-1 Month Momentum % or its related term are showing as below:

TSE:4881's 3-1 Month Momentum % is ranked worse than
80.03% of 1382 companies
in the Biotechnology industry
Industry Median: 0.36 vs TSE:4881: -17.74

FunPep Co  (TSE:4881) 3-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 3-1 Month Momentum % measures the total return to a stock over the past three months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


FunPep Co 3-1 Month Momentum % Related Terms


TSE:4881 vs VRTX, REGN, MRNA: 3-1 Month Momentum % Comparison

For the Biotechnology subindustry, FunPep Co's 3-1 Month Momentum %, along with its competitors' market caps and 3-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FunPep Co 3-1 Month Momentum % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, FunPep Co's 3-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where FunPep Co's 3-1 Month Momentum % falls into.


TSE:4881
50GF Score
FunPep Co Ltd TSE:4881
3-1 Month Momentum % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

FunPep Co  (TSE:4881) 3-1 Month Momentum % Calculation

3-1 Month Momentum % is calculated as following:

3-1 Month Momentum %=( Price 1-month ago / Price 3-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about 3-1 Month Momentum % →
What does a 3-1 Month Momentum % of -17.74% mean?
FunPep Co (TSE:4881) has a 3-1 Month Momentum % of -17.74% as of Sep. 21, 2026. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on FunPep Co and its competitors. According to the industry distribution chart, FunPep Co ranks #1106 out of 1382 companies in the Biotechnology industry, placing it in the top 80%.
Is FunPep Co's 3-1 Month Momentum % too high?
FunPep Co's current 3-1 Month Momentum % is -17.74%. Based on the distribution chart, FunPep Co ranks #1106 out of 1382 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, FunPep Co has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does FunPep Co's 3-1 Month Momentum % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, FunPep Co ranks #1106 out of 1382 companies for 3-1 Month Momentum %. This places FunPep Co in the lower half of its industry. The industry median 3-1 Month Momentum % is 0.36. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-1 Month Momentum % for a Biotechnology company?
The median 3-1 Month Momentum % among Biotechnology companies is 0.36, based on 1,382 companies in the industry. Companies in the top quartile (top 25%) have a 3-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 3-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-1 Month Momentum % mean?
A high 3-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 3-1 Month Momentum measures the total return of the stock from 3-month ago to 1-month ago. View historical data on FunPep Co and its competitors. For the Biotechnology industry, the median 3-1 Month Momentum % is 0.36 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. FunPep Co's current 3-1 Month Momentum % is -17.74%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is FunPep Co stock overvalued right now?
Based on GuruFocus' analysis, FunPep Co (TSE:4881) is currently considered Possible Value Trap. The stock's GF Value™ is 円156.75, compared to a current price of 円50.00 — trading 68.1% below its estimated fair value. The current 3-1 Month Momentum % is -17.74%. FunPep Co's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-1 Month Momentum % calculated?
3-1 Month Momentum % is calculated from a company's financial statements. For FunPep Co (TSE:4881), the current 3-1 Month Momentum % is -17.74% as of Sep. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is FunPep Co (TSE:4881) Overvalued in 2026?

Based on GuruFocus' analysis, FunPep Co stock appears to be undervalued. The current stock price of 円50.00 is trading 68.1% below its estimated GF Value™ of 円156.75. GuruFocus considers FunPep Co to be Possible Value Trap.

Key valuation signals for TSE:4881:

  • 3-1 Month Momentum %: -17.74%
  • GF Value™: 円156.75 vs. price of 円50.00 (68.1% below fair value)
  • GF Score™: 50/100 with 6 warning signs

No single metric tells the full story. See the TSE:4881 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


FunPep Co Business Description

Address Saito Asagi 7-7-15, Osaka Prefecture, No.7 Mizuho Building 3rd Floor, Ibaraki, JPN
FunPep Co Ltd is a biotechnology company focused on the functions of peptides to develop business from cosmetics to medical devices and pharmaceutical products. The company develops drugs related to the intractable peptic ulcer disease. The Group operates in a single segment, which is the research and development of pharmaceuticals.
50GF Score

Get the complete analysis for TSE:4881

3-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円50.00
Price
円156.75
GF Value